 This report contains a case study of late phase cell culture process development where the titer was increased final drug substance quality was maintained and consistent manufacturing was demonstrated for production of an IgG

@highlight Rosmarinic acid RA a new additive increases titer by 100 at 1000 L scale
@highlight Quality attributes were comparable between processes with and without RA
@highlight RA can be integrated in a dry powder basal medium which is easy to use
@highlight A detailed study is presented how to introduce RA into GMP facility
@highlight RA leads to less generation of reactive oxygen species and caspase 3
